Results 101 to 110 of about 278,227 (245)

Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab

European Thyroid Journal
Introduction: Secondary thyroid autoimmunity, especially Graves’ disease (GD), frequently develops in patients with multiple sclerosis (MS) following alemtuzumab treatment (ALTZ; anti-CD52). Thyroid eye disease (TED) can also develop, and rituximab (RTX;
Ilaria Muller, Sara Maioli, Mirco Armenti, Laura Porcaro, Nicola Currò, Elisabetta Iofrida, Lorenzo Pignataro, Jacopo Manso, Caterina Mian, Jens Geginat, Mario Salvi   +10 more
doaj   +1 more source

Clinical assessment of patients with Graves' orbitopathy [PDF]

Medicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor", 2011
Clinical examination is the basis of a good assessment of a patient with Graves' orbitopathy. This study gives recommendations of the European orbitopathy group related to the activity and severity of the disease. The activity of the disease is estimated
Nedeljković-Beleslin Biljana
doaj   +1 more source

Association between G protein polymorphisms (GNAS1 T393C and GNB3 C825T) and course of Graves’ disease and Graves’ orbitopathy [PDF]

, 2011
Summary The biology of initiation and progression of Graves’ hyperthyroidism and Graves’ orbitopathy is complex. For the individually tailored therapy of the diseases it is very important to identify the risk factors.
Dmuchowska, Diana
core  

Imaging of adult ocular and orbital pathology - a pictorial review [PDF]

, 2014
Orbital pathology often presents a diagnostic challenge to the reporting radiologist. The aetiology is protean, and clinical input is therefore often necessary to narrow the differential diagnosis.
Brennan, Paul, Galvin, Patrick Leo, Grech, Reuben, Grech, Stephan, Looby, Seamus, Mizzi, Adrian, O'Hare, Alan, Spiteri Cornish, Kurt, Thornton, John   +8 more
core   +1 more source

Radiological Activity Score (RAS)—MRI Characteristics in Dysthyroid Optic Neuropathy in a Multi‐Ethnic Thyroid Eye Disease Population

Clinical Endocrinology, Volume 103, Issue 3, Page 385-395, September 2025.
ABSTRACT Purpose Dysthyroid Optic Neuropathy (DON) is a sight threatening and diagnostically challenging complication of Thyroid Eye Disease (TED). We provide a comparative analysis of the MRI features associated between patietnts with and without DON. Methods Anonymised retrospective cohort study of patients with TED over eleven years.
Malik Moledina, Vickie Lee, Kunwar Bhatia, Gitta Madani, Claire Feeney, Nicole George, Nour Houbby, Daisy Metcalf, Natalie Man, Rajni Jain, Ahmad Aziz, Ravi Kumar Lingam   +11 more
wiley   +1 more source

Upper eyelid retraction disclosed after edrophonium chloride administration in a patient with Graves' orbitopathy and myasthenia gravis

Clinical Ophthalmology, 2012
Hyera Kang,1,2 Yasuhiro Takahashi,1 Masayoshi Iwaki,1 Shinichi Asamura,3 Hirohiko Kakizaki,11Department of Ophthalmology, Aichi Medical University, Nagakute, Aichi, Japan; 2Department of Ophthalmology, Presbyterian Medical Center, Jeonju, Korea ...
Kang H, Takahashi Y, Iwaki M, Asamura S, Kakizaki H   +4 more
doaj  

Tratamiento de la orbitopatía de Graves [PDF]

, 2019
Nuestro objetivo es realizar un resumen de la patología orbitaria en la enfermedad tiroidea, sus herramientas diagnósticas y las medidas terapéuticas actualizadas, basado en la evidencia científica de la bibliografía específica.
Bustos, Isaías Eduardo
core   +1 more source

Endoscopic orbital decompression for Graves' ophthalmopathy [PDF]

, 2002
Graves’ disease may occasionally result in significant proptosis that is either cosmetically unacceptable or causes visual loss. This has traditionally been managed surgically by external decompression of the orbital bony skeleton. Trans-nasal endoscopic
Carney, A., Thorpe, M., Wee, D., Wormald, P.   +3 more
core   +1 more source

Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy

Frontiers in Endocrinology, 2020
GO is the most frequent extrathyroidal manifestation of Graves’ disease, although it may rarely occur in euthyroid/hypothyroid patients with chronic autoimmune thyroiditis.
L. Bartalena, E. Piantanida, D. Gallo, A. Lai, M. Tanda   +4 more
semanticscholar   +1 more source

Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets

MedComm, Volume 6, Issue 7, July 2025.
This review provides a comprehensive overview of common autoimmune diseases, details clinical manifestations and summarizes the pathogenesis, including the breakdown of immune tolerance, initiation of autoimmune responses, and their progressive amplification.
Xiaoshuang Song, Hantian Liang, Fang Nan, Wenjing Chen, Junyao Li, Liu He, Yiping Cun, Zhenhong Li, Wei Zhang, Dunfang Zhang   +9 more
wiley   +1 more source